Guardian Wealth Management (Illinois)’s GSK GSK Stock Holding History

Guardian Wealth Management (Illinois)’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-107	Closed	-$4.14K	–	121
2025 Q1	$4.14K	Hold	107	–	–	﹤0.01%	189
2024 Q4	$3.62K	Sell	107 -186	-63%	-$6.7K	﹤0.01%	195
2024 Q3	$12K	Hold	293	–	–	0.01%	161
2024 Q2	$11.3K	Hold	293	–	–	0.01%	160
2024 Q1	$12.6K	Sell	293 -44	-13%	-$1.81K	0.01%	153
2023 Q4	$12.5K	Sell	337 -62	-16%	-$2.23K	0.01%	155
2023 Q3	$14.5K	Sell	399 -146	-27%	-$5.18K	0.01%	146
2023 Q2	$19.4K	Hold	545	–	–	0.02%	138
2023 Q1	$19.4K	Sell	545 -3	-0.5%	-$105	0.02%	139
2022 Q4	$19.3K	Sell	548 -133	-20%	-$4.43K	0.02%	145
2022 Q3	$20K	Sell	681 -5	-0.7%	-$190	0.02%	136
2022 Q2	$37K	Buy	686 +2	+0.3%	+$110	0.04%	122
2022 Q1	$37K	Buy	684 +6	+0.9%	+$326	0.04%	133
2021 Q4	$37K	Buy	+678	New	+$35.3K	0.04%	130

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Guardian Wealth Management (Illinois)'s GSK Position: Q2 2025 in Review

Guardian Wealth Management (Illinois) sold out of GSK (GSK) in Q2 2025, closing a stake of 107 shares — an estimated $4.14K sold.

Guardian Wealth Management (Illinois) first reported a position in GSK in Q4 2021 and held it in 14 quarters. The position peaked at $37K in Q2 2022. 890 funds tracked by Wall St. Rank hold GSK as of Q2 2025.

Guardian Wealth Management (Illinois) reported no remaining GSK position as of Q2 2025 after selling out during the quarter.
Guardian Wealth Management (Illinois) sold 107 GSK shares in Q2 2025, an estimated $4.14K.
Guardian Wealth Management (Illinois) first reported a position in GSK in Q4 2021 and held it in 14 quarters.
Guardian Wealth Management (Illinois)'s GSK position peaked at $37K in Q2 2022.
890 funds tracked by Wall St. Rank held GSK as of Q2 2025.

Based on Guardian Wealth Management (Illinois)'s 13F filing for Q2 2025, filed 14 Aug 2025.